Impact of educational attainment on preventive efforts after myocardial infarction: results of the IPP and NET-IPP trials-Reference-Cited by-同舟云学术

Impact of educational attainment on preventive efforts after myocardial infarction: results of the IPP and NET-IPP trials

Published:2023-08-31 Issue: Volume: Page:
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Wienbergen Harm^ORCID,Fach Andreas,Winzer Ephraim B.,Schmucker Johannes,Hanses Ulrich,Retzlaff Tina,Rühle Stephan,Litfin Carina,Kerniss Hatim,Marín Luis Alberto Mata,Elsässer Albrecht,Gielen Stephan,Eitel Ingo,Linke Axel,Hambrecht Rainer,Osteresch Rico

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00392-023-02285-2.pdf

Reference27 articles.

1. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, Benetos A, Biffi A, Boavida JM, Capodanno D et al (2021) 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42(34):3227–3337

2. Ambrosetti M, Abreu A, Corra U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C et al (2020) Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 28(5):460–495

3. Kotseva K, De Backer G, De Bacquer D, Ryden L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A et al (2019) Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol 26:824–835

4. Gitt AK, Lautsch D, Ferrieres J, De Ferrari GM, Vyas A, Baxter CA, Bash LD, Ashton V, Horack M, Almahmeed W et al (2017) Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II. Atherosclerosis 266:158–166

5. Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D et al (2021) EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol 28(11):1279–1289